|
[Related PubMed/MEDLINE]
Total Number of Papers: 25
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2023 |
Long-term transition of antibody titers in healthcare workers following the first to fourth doses of mRNA COVID-19 vaccine: Comparison of two automated SARS-CoV-2 immunoassays. |
GMT, S-RBD, SARS-CoV-2 |
| 2 |
2023 |
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers. |
HCW, NH, WT |
| 3 |
2023 |
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers. |
HCW, NH, WT |
| 4 |
2022 |
Factors associated with humoral immune response in older adults who received egg-free influenza vaccine. |
HAI |
| 5 |
2021 |
A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults. |
GMT, HAI |
| 6 |
2019 |
Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016. |
GMTs, LAIV |
| 7 |
2019 |
Immunogenicity, Safety, and Tolerability of Live Attenuated VaricellaZoster Virus Vaccine (ZOSTAVAX™) in Healthy Adults in India. |
AEs, CIs, GMT, HZ, SAEs, VZV |
| 8 |
2018 |
Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season. |
GMT, HI, LAIV, RT-PCR |
| 9 |
2017 |
Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine. |
AEs, CG, GMT, gpELISA, HAI, SG, VZV, ZV |
| 10 |
2017 |
The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial. |
LZV, RA, VZV |
| 11 |
2016 |
Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial. |
--- |
| 12 |
2016 |
Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults. |
AEs, GMT, gpELISA, HZ, VZV |
| 13 |
2015 |
Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial. |
CI, GMTs, IFN-gamma ELISPOT, IM, s.c, VZV |
| 14 |
2015 |
Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids. |
AEs, GMT, gpELISA, HZ, SAEs, VZV, ZV |
| 15 |
2015 |
The immunogenicity and safety of zoster vaccine in Taiwanese adults. |
GMT, SPS, VZV, ZEST |
| 16 |
2013 |
Naturally occurring IgG antibody levels to the Staphylococcus aureus protein IsdB in humans. |
CI, IsdB |
| 17 |
2013 |
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults. |
gpELISA, HCT, HIV, HM, IFN-gamma ELISPOT, STM, VZV |
| 18 |
2012 |
Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older. |
HA, HI, SCR, SPR |
| 19 |
2012 |
Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis. |
IsdB |
| 20 |
2011 |
Immunogenicity and safety of ZOSTAVAX() approaching expiry potency in individuals aged ≥50 years. |
CI, HZ, PHN, VZV |
| 21 |
2011 |
The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): results of two Phase I studies. |
AE, GMC, IsdB |
| 22 |
2010 |
Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old. |
Ab, AEs, ELISA, GMT, PnPS, VZV |
| 23 |
2010 |
Immunogenicity and safety of a novel AS03(A)-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan. |
GMT, HA, HI |
| 24 |
2010 |
Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster. |
AEs, GMT, HZ, VZV |
| 25 |
2007 |
Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older. |
Ab, AEs, CI, GMT, gpELISA, PV, SCRs, VZV |
|
A Search Service for Abbreviation / Long Form
